For all NHS Lothian Guidelines associated with SACT or SACT Toxicity please access these on OOQs via NHS Lothian Intranet

Guidelines Associated with SACT or SACT Toxicity external website

Systemic anticancer treatment toxicity guidelines can also be found on the RDS: Systemic anticancer treatment toxicity | Right Decisions

All UKONS - Acute Oncology Initial Management Guidelines: https://www.ukacuteoncology.co.uk/download_file/view/356/208 External website

Neutropenic sepsis/febrile neutropenia

Febrile neutropenia is an oncological/haematological emergency.

See guidelines and remember the golden hour.

Follow Sepsis 6, use order sets for bloods and haematology septic screen.

Febrile neutropenia guideline | Right Decisions

Febrile neutropenia | Right Decisions

Ukons Guidelines 2023. Guideline 12. Suspected Neutropenic Sepsis external website

Extravasation

This is the accidental administration of drugs into the extra vascular tissue instead of the vein.

This can happen via cannula or a CVAD.

Can occur during SACT infusion or present post infusion (delayed extravasation).

With certain SACT drugs this cause extensive damage to the surrounding tissue and may cause necrosis. This require immediate action.

Symptoms include swelling, burning/stinging, redness, pain, skin irritation and blistering at the cannula site.

Please follow the extravasation policy external website (accessible on NHS Lothian device).

Suspected extravasation | Right Decisions

Ukons Guidelines 2023. Guideline 34. Extravasation external website

Hypersensitivity

SACT act as foreign substances which can induce hypersensitivity and anaphylactic reactions that range from mild cutaneous symptoms to severe respiratory distress and cardiovascular collapse.

A hypersensitivity reaction is defined as an exaggerated or inappropriate immune response that may be localised or systemic and results in local tissue injury or changes throughout the body in response to an antigen or foreign substance. This reaction can occur rapidly after exposure to an antigen or might take a long time to develop and manifest.

Anaphylaxis is an acute severe multi-system type I hypersensitivity allergic reaction, which has a rapid onset, and can often be life-threatening. It may be precipitated by many SACT agents.

Please see below for full guidelines:

https://g10804.ideagenqpulse.com/QPulseDocumentServiceECC/Documents.svc/documents/active/attachment?number=S%5cTox%5c31 external website [Access via Intranet]

Ukons Guidelines 2023. Guideline 1.Anaphylaxis/Allergic Reaction/Hpyersensitivity external website

Guidelines for the management of Systemic Anti-Cancer therapy (SACT*) induced hypersensitivity- Haematology addendum download [opens a Word document]